Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Positron emission tomography: a technical introduction for clinicians.

Jacobus A K Blokland1, Petar Trindev, Marcel P M Stokkel

  • 1Department of Radiology, Division of Nuclear Medicine, C4Q Leiden University Medical Centre, Albinusdreef 2, 2333 ZA Leiden, The Netherlands. j.a.k.blokland@lumc.nl

European Journal of Radiology
|September 28, 2002
PubMed
Summary

Positron emission tomography (PET) has evolved from an expensive research tool to a cost-effective clinical diagnostic method. Advances in detector technology and radiopharmaceuticals like [(18)F]fluorodeoxyglucose are expanding its use in cancer diagnosis and staging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pyomyositis, a rare complication of a urinary tract infection on FDG PET/CT.

European journal of nuclear medicine and molecular imaging·2026
Same author

Comparative analysis of FES-PET/CT and FDG-PET/CT in patients with ER-positive metastatic invasive lobular breast cancer.

European journal of cancer (Oxford, England : 1990)·2025
Same author

Iodine Seed-Marking Protocol for Response-Guided Axillary Treatment After Systemic Therapy for Node-Positive Breast Cancer.

JAMA oncology·2025
Same author

Pretreatment PET dissemination features as biomarkers for survival outcomes in melanoma patients treated with immune-checkpoint inhibitors.

Scientific reports·2025
Same author

Imaging Proliferation of Stage IV Cutaneous Melanoma With 18 F-FLT PET/CT : A Potential Noninvasive Tool for Predicting Treatment Resistance to Targeted Therapy?

Clinical nuclear medicine·2025
Same author

Theranostics in Perspective: White Paper.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2025

Area of Science:

  • Medical Imaging
  • Nuclear Medicine
  • Radiochemistry

Background:

  • Positron emission tomography (PET) was historically a costly research tool for studying metabolic processes.
  • Recent advancements in detector technology have made PET more accessible for clinical applications.
  • The availability of [(18)F]fluorodeoxyglucose has significantly boosted clinical PET utilization.

Purpose of the Study:

  • To provide a historical overview of Positron Emission Tomography (PET).
  • To offer a technical introduction to PET imaging.
  • To highlight the transition of PET from research to clinical practice.

Main Methods:

  • Review of historical developments in PET technology.
  • Explanation of dual-headed gamma camera systems for radionuclide detection.

Related Experiment Videos

  • Discussion of radiopharmaceutical advancements, specifically [(18)F]fluorodeoxyglucose.

    • Main Results:

    • PET is now a more affordable clinical tool due to improved detector technology.
    • Dual-headed gamma cameras facilitate in vivo radionuclide distribution detection.
    • [(18)F]fluorodeoxyglucose has become a key factor in promoting clinical PET.

    Conclusions:

    • PET technology has transitioned from research to clinical settings, driven by cost reduction and improved accessibility.
    • Ongoing technological developments promise enhanced accuracy in clinical PET imaging.
    • PET is increasingly vital for diagnosing and staging cancer, with future applications anticipated.